Denmark
· Delayed Price · Currency is DKK ViroGates Statistics
Total Valuation
ViroGates has a market cap or net worth of DKK 63.58 million. The enterprise value is 56.67 million.
| Market Cap | 63.58M |
| Enterprise Value | 56.67M |
Important Dates
The last earnings date was Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ViroGates has 7.73 million shares outstanding. The number of shares has increased by 92.52% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.73M |
| Shares Change (YoY) | +92.52% |
| Shares Change (QoQ) | +20.01% |
| Owned by Insiders (%) | 43.83% |
| Owned by Institutions (%) | n/a |
| Float | 3.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.67 |
| PB Ratio | 5.89 |
| P/TBV Ratio | 5.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.95 |
| EV / Sales | 7.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.49.
| Current Ratio | 6.75 |
| Quick Ratio | 5.59 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.13 |
Financial Efficiency
Return on equity (ROE) is -103.19% and return on invested capital (ROIC) is -47.39%.
| Return on Equity (ROE) | -103.19% |
| Return on Assets (ROA) | -43.11% |
| Return on Invested Capital (ROIC) | -47.39% |
| Return on Capital Employed (ROCE) | -96.62% |
| Revenue Per Employee | 714,200 |
| Profits Per Employee | -1.43M |
| Employee Count | 10 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.46% in the last 52 weeks. The beta is 1.14, so ViroGates's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +26.46% |
| 50-Day Moving Average | 9.99 |
| 200-Day Moving Average | 9.04 |
| Relative Strength Index (RSI) | 45.13 |
| Average Volume (20 Days) | 4,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ViroGates had revenue of DKK 7.14 million and -14.35 million in losses. Loss per share was -2.15.
| Revenue | 7.14M |
| Gross Profit | 4.81M |
| Operating Income | -14.56M |
| Pretax Income | -15.18M |
| Net Income | -14.35M |
| EBITDA | -14.52M |
| EBIT | -14.56M |
| Loss Per Share | -2.15 |
Balance Sheet
The company has 12.21 million in cash and 5.30 million in debt, giving a net cash position of 6.91 million or 0.89 per share.
| Cash & Cash Equivalents | 12.21M |
| Total Debt | 5.30M |
| Net Cash | 6.91M |
| Net Cash Per Share | 0.89 |
| Equity (Book Value) | 10.80M |
| Book Value Per Share | 1.40 |
| Working Capital | 14.89M |
Cash Flow
| Operating Cash Flow | -11.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.33%, with operating and profit margins of -203.86% and -200.85%.
| Gross Margin | 67.33% |
| Operating Margin | -203.86% |
| Pretax Margin | -212.55% |
| Profit Margin | -200.85% |
| EBITDA Margin | -203.30% |
| EBIT Margin | -203.86% |
| FCF Margin | n/a |
Dividends & Yields
ViroGates does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -92.52% |
| Shareholder Yield | -92.52% |
| Earnings Yield | -22.56% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ViroGates has an Altman Z-Score of 3.57.
| Altman Z-Score | 3.57 |
| Piotroski F-Score | n/a |